Solius Labs Launches World’s First Personalized Sunlight Medical Device (opens original article in a new tab)

Solius Labs introduced Solius Pro, the first FDA-cleared personalized UVB light therapy device that delivers optimal UVB doses with significantly reduced risk compared to sunlight, available without a prescription.

• Solius Labs launched Solius Pro, an FDA-cleared personalized UVB light therapy device that analyzes skin to deliver optimal UVB doses with 99% less UV risk than sunlight.
• The device uses a patent-pending skin analysis system to determine personalized UVB doses, offering 12x more UVB biological benefit than sunlight with reduced risk.
• Solius Pro is available over-the-counter and has received a new FDA product code, SGZ, for UVB light therapy to stimulate vitamin D production.